Industry NewsDrug discovery > Clinical Development Phase III study shows Xolair may be more effective with fewer adverse effects for the treatment of food allergies
Industry NewsLife Sciences Food allergy doubles in the UK over last decade but many still without treatment
Cross-reactive carbohydrate determinants and their relevance to in vitro allergy diagnosticsAvailable on-demand
